lyrica
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-operative Pain
Conditions
Post-operative Pain
Trial Timeline
Dec 1, 2006 → Jun 1, 2013
NCT ID
NCT01391858About lyrica
lyrica is a phase 3 stage product being developed by Pfizer for Post-operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01391858. Target conditions include Post-operative Pain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01391858 | Phase 3 | Completed |
Competing Products
18 competing products in Post-operative Pain